Palbociclib-d8
Palbociclib-d8 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Palbociclib. The product is supplied by Clearsynth under CAT No. CS-O-15447. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Product Specifications
Overview
"Palbociclib-d8 is labelled Palbociclib, an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
CAS Number
1628752-83-9
Synonyms
Palbociclib-d8
Molecular Formula
C 24 H 21 D 8 N 7 O 2
Molecular Weight
455.58
Additionnal Information
Palbociclib-d8 is supplied with detailed characterization data compliant with regulatory guideline. Palbociclib-d8 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Palbociclib.
Storage Conditions
Refer MSDS for complete information.
Applications Notes
"Palbociclib-d8 is labelled Palbociclib, an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
HSN Code
38229010
Hazard Compound
Refer MSDS for accurate information.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1069040-01 50 mg
Tert-Butyl 3-amino-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate
Sign In for Pricing
View Details OR1069040-02 100 mg
Tert-Butyl 3-amino-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate
Sign In for Pricing
View Details OR1069040-03 250 mg
Tert-Butyl 3-amino-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate
Sign In for Pricing
View Details